Ellie provides a research-backed, week-by-week framework for maintaining weight loss after stopping or reducing GLP-1 drugs, including trend tracking and prescriber-friendly exports.
The website review directory that helps you rank on Google, ChatGPT, Claude, Gemini & Perplexity with dofollow backlinks and AI reviews.
Submit your website to get discovered by thousands of potential customers and boost your SEO.
Get ListedEllie is a mobile health application designed for individuals transitioning off GLP-1 medications such as Ozempic, Wegovy, Zepbound, and Mounjaro. It addresses the underserved phase after active weight loss by providing a structured, week-by-week maintenance plan based on clinical extension studies and real-world discontinuation data. The app enables users to define a personal weight ceiling, tracks seven-day trends, and triggers early interventions at roughly 4 lbs of drift. Targeting anyone tapering, stretching doses, or fully discontinuing, Ellie combines daily logging, protein and strength goals, and a panic button for food cravings into a single companion tool.
The app is suitable for patients who have completed a GLP-1 treatment cycle and want to sustain their results. It is also useful for those experiencing side effects or financial constraints that necessitate dose reduction. Healthcare providers can use the export feature to monitor patient adherence and tailor clinical decisions. Dietitians and health coaches integrating GLP-1 support into their practice can leverage Ellie as a patient-facing accountability mechanism. The free tools section serves as an educational resource for individuals investigating GLP-1 discontinuation before committing to the app.